NFKB1 and nasopharyngeal carcinoma: The dominance of NF-κB activation in NPC that we have identified is consistent with recent genome-wide CRISPR-based gene knockout screens and functional studies showing that perturbation of the NF-κB pathway significantly inhibited the growth of EBV-positive NPC cells8,20,41,42.